Delivery Order SPE2DB22D2009-SPE2DB25FM0MM
- Not listed
- The Defense Logistics Agency awarded a $157,016.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine product, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order was awarded on July 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $92,818.40 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a $2,195.46 delivery order to AmerisourceBergen Drug Corp for one vial of Menveo (meningococcal conjugate vaccine A-C-Y-W-135) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,152.10 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine procurement action supporting...
- The Defense Logistics Agency awarded a $25,657.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine used for immunization against meningococcal disease. This non-set-aside competitive award is scheduled for completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $15,760.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo (meningococcal vaccine) in a single-vial formulation (A-C-Y-W-135-DIP, 0.5mL). This non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement through established federal...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Menveo vaccine in a 10-dose vial configuration. This firm fixed-price delivery order, valued at $31,234.74, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The award, which carries no set-aside designation, reflects a competitively awarded...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of $5,107.64 worth of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccines. This delivery order has a completion date of February 29, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which was not set aside under any specific program. Additionally, AmerisourceBergen Drug Corp holds an...
- The Defense Logistics Agency Troop Support Medical awarded a $11,053.92 firm fixed price delivery order to Amerisourcebergen Drug Corp for MENVEO vaccine. The delivery order is for five doses of the vaccine to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 5, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will perform as the prime contractor. No major subcontractors or set aside designations were indicated. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $9,182.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for a Menveo A-C-Y-W Kit (2 vials) on July 18, 2025. The order, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside contract with performance occurring at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0MMDelivery Order
The Defense Logistics Agency awarded a $169,665.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency Medical Supply Chain. The company demonstrates significant capability in delivering diverse medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Menveo vaccine aligns with the company's established role as a critical vendor for federal medical procurement needs, fulfilling ongoing vaccination and immunization requirements for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $169.7k | 7/25/25 |